Sun Pharma’s U.S. Arm Agrees To Settle Multi-Million Dollar Drug Price-Fixing Charges
Pills arranged for a photograph in Tokyo, Japan. (Photographer: Kiyoshi Ota/Bloomberg)

Sun Pharma’s U.S. Arm Agrees To Settle Multi-Million Dollar Drug Price-Fixing Charges

Sun Pharmaceutical Industries Ltd.’s U.S. subsidiary has agreed to pay more than $400 million to settle charges that it conspired to fix prices of generic drugs, in a long-running investigation by ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.